Log In
Print this Print this

Vancocin, vancomycin

Also known as: Vancocin Pulvules

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionTricyclic glycopeptide antibiotic
Molecular Target D-alanyl-D-alanine
Mechanism of ActionCell wall synthesis inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationDiarrhea (infectious)
Indication DetailsTreat staphylococcal enterocolitis, Clostridium difficile-associated colitis and Clostridium difficile-associated diarrhea (CDAD) infections
Regulatory Designation
Partner ANI Pharmaceuticals Inc.; ANI Pharmaceuticals Inc.; Merus Labs International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today